Ingrid M. Saldana-Guerrero

Ingrid M. Saldana-Guerrero

Auto-generated profile, based on publicly available information

Ingrid M. Saldana-Guerrero

Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield, Sheffield, UK

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
DSDylan Stavish
Dylan Stavish
CBCharlotta Böiers
Charlotta Böiers
CPChristopher Price
Christopher Price
TFThomas J. R. Frith
Thomas J. R. Frith
JHJason Halliwell
Jason Halliwell
TETariq Enver
Tariq Enver
We postulate that exit from pluripotency involves intermediates that retain pluripotency while simultaneously exhibiting lineage-bias. Using a MIXL1 reporter, we explore mesoderm lineage-bias within the human pluripotent stem cell compartment. We identify a substate, which at the single cell level coexpresses pluripotent and mesodermal gene expression programmes. Functionally these cells initiate stem cell cultures and exhibit mesodermal bias in differentiation assays. By promoting mesodermal identity through manipulation of WNT signalling while preventing exit from pluripotency using lysophosphatidic acid, we ‘trap’ and maintain cells in a lineage-biased stem cell state through multiple passages. These cells correspond to a normal state on the differentiation trajectory, the plasticity of which is evidenced by their reacquisition of an unbiased state upon removal of differentiation cues. The use of ‘cross-antagonistic’ signalling to trap pluripotent stem cell intermediates with different lineage-bias may have general applicability in the efficient production of cells for regenerative medicine.

3 May 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
ISIngrid M. Saldana-Guerrero
Ingrid M. Saldana-Guerrero
LMLuis F. Montano-Gutierrez
Luis F. Montano-Gutierrez
KBKaty Boswell
Katy Boswell
CHChristoph Hafemeister
Christoph Hafemeister
EPEvon Poon
Evon Poon
FHFlorian Halbritter
Florian Halbritter
Early childhood tumours arise from transformed embryonic cells, which often carry large copy number alterations (CNA). However, it remains unclear how CNAs contribute to embryonic tumourigenesis due to a lack of suitable models. Here we employ female human embryonic stem cell (hESC) differentiation and single-cell transcriptome and epigenome analysis to assess the effects of chromosome 17q/1q gains, which are prevalent in the embryonal tumour neuroblastoma (NB). We show that CNAs impair the specification of trunk neural crest (NC) cells and their sympathoadrenal derivatives, the putative cells-of-origin of NB. This effect is exacerbated upon overexpression of MYCN, whose amplification co-occurs with CNAs in NB. Moreover, CNAs potentiate the pro-tumourigenic effects of MYCN and mutant NC cells resemble NB cells in tumours. These changes correlate with a stepwise aberration of developmental transcription factor networks. Together, our results sketch a mechanistic framework for the CNA-driven initiation of embryonal tumours.

23 November 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
ISIngrid M. Saldana-Guerrero
Ingrid M. Saldana-Guerrero
LMLuis F. Montano-Gutierrez
Luis F. Montano-Gutierrez
KBKaty Boswell
Katy Boswell
CHChristoph Hafemeister
Christoph Hafemeister
EPEvon Poon
Evon Poon
FHFlorian Halbritter
Florian Halbritter
Early childhood tumours arise from transformed embryonic cells, which often carry large copy number alterations (CNA). However, it remains unclear how CNAs contribute to embryonic tumourigenesis due to a lack of suitable models. Here we employ female human embryonic stem cell (hESC) differentiation and single-cell transcriptome and epigenome analysis to assess the effects of chromosome 17q/1q gains, which are prevalent in the embryonal tumour neuroblastoma (NB). We show that CNAs impair the specification of trunk neural crest (NC) cells and their sympathoadrenal derivatives, the putative cells-of-origin of NB. This effect is exacerbated upon overexpression of MYCN , whose amplification co-occurs with CNAs in NB. Moreover, CNAs potentiate the pro-tumourigenic effects of MYCN and mutant NC cells resemble NB cells in tumours. These changes correlate with a stepwise aberration of developmental transcription factor networks. Together, our results sketch a mechanistic framework for the CNA-driven initiation of embryonal tumours.